# Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia

> **NCT06916403** · — · ACTIVE_NOT_RECRUITING · sponsor: **Wilderman Medical Clinic** · enrollment: 50 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Intravenous Ketamine Infusions

## Key facts

- **NCT ID:** NCT06916403
- **Lead sponsor:** Wilderman Medical Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916403, "Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06916403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*